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Introduction
T h ep r e s e n c eo fi s c h e m i a - induced microvascular
obstruction (MVO) despite successful coronary revascu-
larization, has been associated with poor functional
recovery and adverse left ventricular remodeling after
acute myocardial infarction (AMI). Additionally, the
extent of the infarct gray zone is a strong independent
predictor of post-AMI mortality. However, the evolution
of gray zone after AMI has not been investigated and its
relationship with MVO in terms of risk stratification is
unknown.
Purpose
To characterize the evolution of gray zone and deter-
mine its correlation with the presence of MVO during
infarct healing in patients treated with primary percuta-
neous coronary intervention (PCI).
Methods
Patients were enrolled post-PCI and underwent MRI
examination on a 1.5T scanner (GE Signa Excite) at day
2, week 4 and month 6 following AMI. Cardiac function
[Ejection fraction (EF), End-diastolic volume (EDV)] was
evaluated using a steady-state-free-precession (SSFP)
sequence in cine mode. A T1-weighted IR-GRE
sequence was used for delayed-hyperenhancement
(DHE) of infarcted myocardium. Infarct core (IC) and
gray zone (GZ) volumes were quantified using the full-
width-half-maximum technique as previously described;
both quantities were expressed as a percentage of myo-
cardial volume. MVO’s were manually traced and
included in the infarct core calculation.
Results
Ten patients who completed MRI exams at all
three time points were included in the study [mean age:
59.7±11 years; 9 males, 1 female; 4 right coronary artery
and 2 left circumflex artery PCI; MVO was identified in
4 patients]. Figure 1 shows DHE images from represen-
tative patients in the MVO and non-MVO groups while
Tables 1, 2, 3 summarize the corresponding quantities
measured. Note that the following findings were signifi-
cant: (a) infarct core was reduced in all patients by
month 6; (b) MVO was resolved by week 4; (b) gray
zone size relative to infarct size, GZr = 100*GZ/(GZ+IC)
increased in the MVO group at month 6 while it
remained stable in the non-MVO group; (d) EF was
reduced in the MVO group compared to the non-MVO
at all time points (p<0.05). The percent change in GZr
(ΔGZr)a tw e e k4a n dm o n t h6 ,r e l a t i v et od a y2i s
shown in Figure 2.
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Figure 1 Delayed-enhanced short-axis slices from two
representative patients in the MVO and non-MVO groups imaged at
three different time points post AMI. Color coding identifies three
regions: Infarct core (green), gray zone (yellow) and microvascular
obstruction (red).
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The increase in infarct gray zone or arrhythmogenic
substrate may be one of the possible mechanisms
responsible for adverse remodeling and poor clinical
prognosis in patients with MVO. Monitoring the early
evolution of gray zone in the high-risk patients could
also potentially help identify the optimal timing and
candidates for placement of implantable cardioverter-
defibrillator.
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Table 1 All patients (N=10)
Day 2 Week 4 Month 6
GZ (%) 7.8±3.5 7.4±6.0 7.2±5.0
IC (%) 18.5±11.6 12.2±8.1 * 11.5±8.1 *
MVO (%) 3.5±5.1 0.2±0.3 0.2±0.4
EF (%) 47.4±7.1 49.8±7.8 51.5±11.1
EDV (ml) 123.2±30.3 143.9±33.0 117.0±23.8
GZr (%) 31.4±7.8 37.4±17.0 38.1±11.7
Values have been expressed as mean±standard deviation.
p-values were measured with respect to day 2 measurements by paired
Students t-test.
* p<0.01.
Table 2 non-MVO patients (N=6)
Day 2 Week 4 Month 6
GZ (%) 6.6±3.1 4.4±2.3 ** 4.5±2.7
IC (%) 11.8±4.5 8.9±6.6 7.5±5.3 **
MVO (%) 0 0 0
EF (%) 50.8±7.3 53.3±8.3 57.5±7.1
EDV (ml) 134.6±27.4 135.0±22.9 117.6±23.7
GZr (%) 34.5±5.7 30.3±11.8 33.6±10.2
Values have been expressed as mean±standard deviation.
p-values were measured with respect to day 2 measurements by paired
Students t-test.
** p<0.05.
Table 3 MVO patients (N=4)
Day 2 Week 4 Month 6
GZ (%) 9.7±3.6 12.0±7.2 11.3±5.0
IC (%) 28.5±12.0 17.2±8.2 ** 17.5±8.5 **
MVO (%) 8.7±4.2 0.4±0.5 ** 0.4±0.6 **
EF (%) 42.2±3.0 44.6±3.0 42.3±10.0
EDV (ml) 106.1±29.1 157.3±44.7 * 116.2±27.6 *
GZr (%) 26.1±8.7 39.4±18.5 38.9±10.7 **
Values have been expressed as mean±standard deviation.
p-values were measured with respect to day 2 measurements by paired
Students t-test.
* p<0.01, ** p<0.05.
Figure 2 Plot demonstrates the change in GZr at two time points
(t) i.e. week 4 and month 6 relative to the initial measurement at
day 2. Error bars indicate standard error.
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